U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07721155) titled 'Objective Neurocognitive Assessment of Young Children With Sickle Cell Disease by Eye-Tracking' on June 22.
Brief Summary: Evidence indicates that Sickle Cell Disease (SCD) threatens neurodevelopmental outcome. Although children with SCD may be heterogeneously affected, neurocognitive impairment may already be present in toddlers. Neurocognitive functioning is an important determinant of adaptive daily life functioning later in life and is influenced by both the course of the disease and the often suboptimal environment in which afflicted children grow up. Early identification of children at the highest risk of neurocognitive impair...